News - Dermatologicals

Filter

Current filters:

Dermatologicals

Popular Filters

100 to 117 of 117 results

Stellar Pharma to sell Apricus MycoVa in Canada

04-01-2012

USA-based Apricus Biosciences (Nasdaq: ARI) has signed an exclusive license agreement with Canada’s…

Apricus BioscienceDermatologicalsLicensingMycoVaNorth AmericaPharmaceuticalStellar Pharmaceuticals

FTC stipulates divestments for Valeant acquisitions

14-12-2011

Canada’s Valeant Pharmaceuticals International (TSX: VRX) has been ordered by the USA’s Federal…

DermatologicalsDermikMergers & AcquisitionsNorth AmericaPharmaceuticalValeant Pharmaceuticals

Sinclair IS buys derma company

08-12-2011

UK specialty drugmaker Sinclair IS Pharma plc (AIM: SPH.L) has entered into an agreement to acquire USA-based…

Advanced Bio-TechnologiesDermatologicalsKelo-coteMergers & AcquisitionsPharmaceuticalSinclair IS Pharma

USA’s SOHM acquires Novatrend to expand presence in India

28-11-2011

California, USA-based generic drugmaker SOHM (Pinksheets: SHMN) has announced the acquisition of business…

Asia-PacificDermatologicalsGenericsMergers & AcquisitionsNovatrend MedicamentPharmaceuticalSOHM

Pfizer to buy Excaliard, gaining rights to Ph II skin scarring product

23-11-2011

Global pharma behemoth Pfizer (NYSE: PFE) says it has entered into a definitive agreement to acquire…

DermatologicalsExcaliard PharmaIsis PharmaceuticalsMergers & AcquisitionsPfizerPharmaceutical

46% of US dermatologists expect to prescribe Pfizer’s tofacitinib to psoriasis patients who failed one biologic

17-11-2011

In the first year following its approval for psoriasis, nearly one-half (46%) of surveyed dermatologists…

apremilastCelgeneDermatologicalsMarkets & MarketingNorth AmericaPfizerPharmaceuticaltofacitinib

Invida acquires portfolio of derma and primary care products from Shalaks for marketing in India

14-11-2011

Singapore-headquartered Invida Holdings, a leading specialty biopharmaceutical company focused on the…

Asia-PacificDermatologicalsInvidaMergers & AcquisitionsPharmaceuticalShalaks Pharma

Psoriasis drug market set to see strong growth until 2018, reaching a value of $6.7 million

28-09-2011

The psoriasis therapeutics market is forecast to show high growth until 2018 and market research firm…

DermatologicalsGlobalImmunologicalsMarkets & MarketingPharmaceutical

Many European dermatologists want more post-marketing data before Rxing Pfizer’s Janus

12-09-2011

At least half of surveyed dermatologists across the EU5 (France, Germany, Italy, Spain and the UK) will…

BiotechnologyDermatologicalsEuropeJanusMarkets & MarketingPfizerPharmaceuticaltofacitinib

Shire drops Dermagraft for venous leg ulcers, after Ph III failure

25-08-2011

Ireland-headquartered drugmaker Shire (LSE: SHP) says that Advanced BioHealing (ABH), the USA-based regenerative…

Advanced BioHealingBiotechnologyDermagraftDermatologicalsPharmaceuticalRegulationResearchShire

Independent Nycomed US names ex-King Pharma execs as CEO, COO and CFO

01-08-2011

Nycomed US Inc has announced the appointment of Brian Markison as president and chief executive Officer…

DermatologicalsKing PharmaceuticalsManagementNycomed USPharmaceutical

Allergan to acquire derma firm Vicept for up to $275 million

21-07-2011

US drugmaker Allergan (NYSE: AGN) has entered into a definitive agreement for to acquire all of the outstanding…

AllerganDermatologicalsMergers & AcquisitionsPharmaceuticalVicept Therapeutics

Valeant to acquire J&J’s Ortho Dermatologics for $345 million

18-07-2011

Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) says it has signed an…

DermatologicalsJohnson & JohnsonMergers & AcquisitionsOrtho-McNeil-JanssenPharmaceuticalValeant Pharmaceuticals

Valeant to buy Sanofi’s skin care unit Dermik for $425 million

11-07-2011

Canada’s Valeant Pharmaceuticals International (TSX: VRX) has entered into an agreement to acquire…

DermatologicalsDermikMergers & AcquisitionsNorth AmericaPharmaceuticalSanofiValeant Pharmaceuticals

Spain’s Almirall launches Sativex and gets OK for Actikerall in Germany

06-07-2011

Spain’s largest pharmaceutical firm, Almirall (ALM: MC) yesterday announced the German launch of…

ActikerallAlmirallDermatologicalsEuropeGW PharmaceuticalsMarkets & MarketingNeurologicalOncologyPharmaceuticalRegulationSativex

US pharma has 277 medicines in development for skin diseases

15-06-2011

The USA’s biopharmaceutical research companies currently are developing 277 medicines to help the…

DermatologicalsNorth AmericaPharmaceuticalResearch

AstraZeneca gains rights to Heptares GPCR drug for $6.25 million upfront

31-05-2011

Anglo-Swedish drug major AstraZeneca (LSE: AZN) revealed this morning that it has entered a four-year…

AstraZenecaDermatologicalsHeptares TherapeuticsLicensingNeurologicalPharmaceuticalResearch

100 to 117 of 117 results

Back to top